Salcaprozate sodium
Salcaprozate sodium has been studied in 3 papers since 2026: 1 trial in people, 2 in animals; 3 in the past year. The newest paper, Nov 3, 2026: “Discovery, optimization, and Phase 1 evaluation of a novel, orally available GLP-1R/GIPR dual agonist”.
2 new papers in 30 daysSee all 4 papers on salcaprozate sodium
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country; 2 trials, none about aging.
None of its findings points the other way.
- 1 lab in 1 country
- 2 trials, none about aging
- Funder: Hospital Research Foundation
- Human trial1
- Animals2
What is salcaprozate sodium linked with?
5Studies link salcaprozate sodium with 5 measures, among them liver weight, BDNF and TNF-alpha.
Liver weight
upin rats1
1 study
Liver weight
upin rats1
Salcaprozate sodium is associated with liver weight in rats (healthy rats).
“SNAC-treated animals also exhibited increased liver weight and reduced caecum mass”
Animalshealthy ratsliver22 mg/kg/day21 days
Journal of controlled release : official journal of the Controlled Release Society
BDNF
downin rats1−85%
1 study
BDNF
downin rats1−85%
Salcaprozate sodium is associated with BDNF in rats (healthy rats; monotherapy) (−85%).
“Plasma cytokine analysis showed elevated tumor necrosis factor-α (TNF-α, 70%) and suppressed brain-derived neurotrophic factor (BDNF, 85%)”
Animalshealthy rats; monotherapy22 mg/kg/day21 days
Journal of controlled release : official journal of the Controlled Release Society
TNF-alpha
upin rats1+70%
1 study
TNF-alpha
upin rats1+70%
Salcaprozate sodium is associated with TNF-alpha in rats (healthy rats; monotherapy) (+70%).
“Plasma cytokine analysis showed elevated tumor necrosis factor-α (TNF-α, 70%) and suppressed brain-derived neurotrophic factor (BDNF, 85%)”
Animalshealthy rats; monotherapy22 mg/kg/day21 days
Journal of controlled release : official journal of the Controlled Release Society
Fecal butyrate
downin rats1−77%
1 study
Fecal butyrate
downin rats1−77%
Salcaprozate sodium is associated with fecal butyrate in rats (healthy rats) (−77%).
“These compositional changes correlated with reduced predicted saccharolytic enzyme abundance and fecal butyrate concentrations (-77% SNAC, -75% SEM-SNAC).”
Animalshealthy rats22 mg/kg/day21 days
Journal of controlled release : official journal of the Controlled Release Society
Gut microbiota composition
mixedin rats1
1 study
Gut microbiota composition
mixedin rats1
Salcaprozate sodium is associated with gut microbiota composition in rats (healthy rats; compared with the control group) (Muribaculaceae −62%; Bacteroidaceae −77%; β-diversity PERMANOVA p < 0.05).
“SNAC significantly altered β-diversity (PERMANOVA, p < 0.05) and depleted primary fermenters in Muribaculaceae (-62%) and Bacteroidaceae (-77%) compared to the control group.”
Animalshealthy rats; compared with the control groupgut22 mg/kg/day21 days
Journal of controlled release : official journal of the Controlled Release Society
Trial sponsors
Company2 trialsPhase 182 people